U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
173281173281Familial Barrett's EsophagusRecruitingNo Results AvailableBarrett's Esophagus|Esophageal Neoplasmhttps://ClinicalTrials.gov/show/NCT00288119
173282173282S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPTTerminatedNo Results AvailableProstate CancerOther: Follow-uphttps://ClinicalTrials.gov/show/NCT00288106
1732831732833-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By SurgeryActive, not recruitingNo Results AvailablePancreatic Adenocarcinoma|Stage III Pancreatic CancerRadiation: 3-Dimensional Conformal Radiation Therapy|Drug: Triapinehttps://ClinicalTrials.gov/show/NCT00288093
173284173284Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate CancerActive, not recruitingNo Results AvailableProstate CancerDrug: bicalutamide|Drug: buserelin|Drug: docetaxel|Drug: flutamide|Drug: goserelin acetate|Drug: leuprolide acetate|Drug: prednisone|Drug: triptorelin|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00288080
173285173285Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin LymphomaTerminatedHas ResultsAdult Nodular Lymphocyte Predominant Hodgkin Lymphoma|B-cell Chronic Lymphocytic Leukemia|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage IIDrug: fenretinide|Drug: rituximabhttps://ClinicalTrials.gov/show/NCT00288067
173286173286S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerTerminatedHas ResultsLung CancerBiological: cetuximab|Drug: docetaxel|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00288054
173287173287Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic MelanomaCompletedNo Results AvailableCiliary Body and Choroid Melanoma, Medium/Large Size|Extraocular Extension Melanoma|Iris Melanoma|Recurrent Intraocular Melanoma|Recurrent Melanoma|Stage IV MelanomaDrug: carboplatin|Drug: paclitaxel|Drug: bortezomibhttps://ClinicalTrials.gov/show/NCT00288041
173288173288Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell TransplantCompletedNo Results AvailableMultiple Myeloma and Plasma Cell NeoplasmDrug: bortezomibhttps://ClinicalTrials.gov/show/NCT00288028
173289173289Bevacizumab in Treating Patients With AngiosarcomaActive, not recruitingNo Results AvailableSarcomaBiological: Bevacizumabhttps://ClinicalTrials.gov/show/NCT00288015
173290173290Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast CancerCompletedNo Results AvailableBreast CancerBiological: trastuzumab|Drug: capecitabine|Drug: cyclophosphamide|Drug: docetaxel|Drug: epirubicin hydrochloride|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00288002
173291173291Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: carboplatin|Drug: erlotinib hydrochloride|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00287989
173292173292Irinotecan in Treating Young Patients With Refractory or Recurrent HepatoblastomaActive, not recruitingNo Results AvailableLiver CancerDrug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00287976
173293173293Topotecan and Vinorelbine in Treating Patients With Recurrent Lung CancerCompletedNo Results AvailableLung CancerDrug: topotecan hydrochloride|Drug: vinorelbine tartratehttps://ClinicalTrials.gov/show/NCT00287963
173294173294Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With NeuroblastomaActive, not recruitingNo Results AvailableNeuroblastomaDrug: carboplatin|Drug: cisplatin|Drug: cyclophosphamide|Drug: etoposide|Drug: vincristine sulfate|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00287950
173295173295Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: vorinostat|Drug: paclitaxel|Drug: carboplatin|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00287937
173296173296High-Dose Methotrexate in Treating Young Patients With Residual EpendymomaActive, not recruitingNo Results AvailableBrain and Central Nervous System TumorsDrug: methotrexate|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00287924
173297173297Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical CancerCompletedNo Results AvailableCervical CancerDrug: cisplatin|Drug: topotecan hydrochloride|Radiation: brachytherapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00287911
173298173298Telephone-Based Genetic Counseling or Standard Genetic Counseling in Women at Risk of Carrying the BRCA1 or BRCA2 MutationActive, not recruitingNo Results AvailableBreast CancerGenetic: mutation analysis|Other: counseling interventionhttps://ClinicalTrials.gov/show/NCT00287898
173299173299Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic CancerCompletedNo Results AvailableCervical Cancer|Endometrial Cancer|Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer|Sarcoma|Vaginal Cancer|Vulvar CancerDrug: docetaxelhttps://ClinicalTrials.gov/show/NCT00287885
173300173300Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple MyelomaCompletedHas ResultsMultiple MyelomaDrug: bortezomib|Drug: thalidomidehttps://ClinicalTrials.gov/show/NCT00287872
173301173301Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerTerminatedNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity CancerDrug: topotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00287859
173302173302Imatinib Mesylate in Treating Patients With Recurrent or Refractory FibromatosisRecruitingNo Results AvailableDesmoid TumorDrug: imatinib mesylatehttps://ClinicalTrials.gov/show/NCT00287846
173303173303Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Healthy MenCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificOther: placebo|Drug: Bowman-Birk inhibitor concentratehttps://ClinicalTrials.gov/show/NCT00287833
173304173304Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid MetabolismCompletedNo Results AvailableSchizophrenia|Diabetes|Metabolic Syndrome|HyperglycemiaDrug: Olanzapine|Drug: olanzapine|Drug: risperidonehttps://ClinicalTrials.gov/show/NCT00287820
173305173305Effect of Self-monitoring of Blood Glucose in Patients With Type 2 Diabetes Mellitus Not Using InsulinCompletedNo Results AvailableDiabetes Mellitus, Type 2Behavioral: Self-monitoring of blood glucose (SMBG)https://ClinicalTrials.gov/show/NCT00287807
173306173306Quality of Sleep in Patients With Rheumatoid ArthritisRecruitingNo Results AvailableRheumatoid ArthritisDrug: diazepam, melatoninhttps://ClinicalTrials.gov/show/NCT00287794
173307173307A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine HeadacheCompletedNo Results AvailableMigraine HeadacheDrug: Lidocainehttps://ClinicalTrials.gov/show/NCT00287781
173308173308Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric CancerCompletedNo Results AvailableGastric CancerDrug: docetaxel + S-1|Drug: S-1https://ClinicalTrials.gov/show/NCT00287768
173309173309Clinical Trial of Chemosensitivity TestCompletedNo Results AvailableGastric CancerDrug: S-1https://ClinicalTrials.gov/show/NCT00287755
173310173310A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's DiseaseTerminatedNo Results AvailableAlzheimer's Disease|DementiaDrug: risperidonehttps://ClinicalTrials.gov/show/NCT00287742

* Görseller ve İçerik tekif hakkına sahip olabilir